D
Tourmaline Bio, Inc. TRML
$15.84 -$0.08-0.50%
Recommendation
Sell
Prev Close
$15.45
Volume
191,659
Avg Vol (90D)
339,517
Market Cap
$396.24M
Dividend & Yield
--
52-Week Range
$9.18 - $48.31
P/E (TTM)
--
EPS (TTM)
-$2.77
My Lists My Alerts
Report
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Tourmaline Bio (TRML, $15.84) Aroon Indicator entered a Downtrend on May 03, 2024.
5/4/2024 - Tickeron - Stocks
Tourmaline Bio (TRML, $15.92) Aroon Indicator entered a Downtrend on May 02, 2024.
5/3/2024 - Tickeron - Stocks
Tourmaline Bio (TRML, $15.74) Aroon Indicator entered a Downtrend on May 01, 2024.
5/2/2024 - Tickeron - Stocks
Tourmaline Bio (TRML, $15.83) Aroon Indicator entered a Downtrend on April 30, 2024.
5/1/2024 - Tickeron - Stocks
Tourmaline Bio, Inc. (NASDAQ:TRML) Short Interest Up 20.9% in April
4/30/2024 - Ticker Report
Tourmaline Bio (TRML, $15.5) Aroon Indicator entered a Downtrend on April 29, 2024.
4/30/2024 - Tickeron - Technical Analysis
Short Interest in Tourmaline Bio, Inc. (NASDAQ:TRML) Expands By 20.9%
4/29/2024 - Zolmax
Tourmaline Bio (TRML, $15.68) Aroon Indicator entered a Downtrend on April 26, 2024.
4/27/2024 - Tickeron - Stocks
Tourmaline Bio (TRML, $16) Aroon Indicator entered a Downtrend on April 25, 2024.
4/26/2024 - Tickeron - Stocks
The volume for Tourmaline Bio stock increased for one day, resulting in a record-breaking daily growth of 307% of the 65-Day Volume Moving Average
4/25/2024 - Tickeron - Stocks
Tourmaline Bio (TRML, $15.41) Aroon Indicator entered a Downtrend on April 24, 2024.
4/25/2024 - Tickeron - Stocks
Tourmaline Bio (TRML, $15.09) Aroon Indicator entered a Downtrend on April 23, 2024.
4/24/2024 - Tickeron - Technical Analysis
Tourmaline Bio (TRML, $15.5) Aroon Indicator entered a Downtrend on April 22, 2024.
4/23/2024 - Tickeron - Stocks
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $61.80 Average Target Price from Brokerages
4/23/2024 - Ticker Report
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $61.80 Average PT from Brokerages
4/21/2024 - Zolmax
Tourmaline Bio (TRML, $15.45) Aroon Indicator entered a Downtrend on April 19, 2024.
4/20/2024 - Tickeron - Stocks
Tourmaline Bio (TRML, $15.66) Aroon Indicator entered a Downtrend on April 18, 2024.
4/19/2024 - Tickeron - Stocks
Tourmaline Bio (TRML, $16.68) Aroon Indicator entered a Downtrend on April 17, 2024.
4/18/2024 - Tickeron - Stocks
Tourmaline Bio (TRML, $17.86) Aroon Indicator entered a Downtrend on April 16, 2024.
4/17/2024 - Tickeron - Stocks
Head-To-Head Analysis: Tourmaline Bio (NASDAQ:TRML) and Caribou Biosciences (NASDAQ:CRBU)
4/17/2024 - Zolmax
Tourmaline Bio (TRML, $18.99) Aroon Indicator entered a Downtrend on April 15, 2024.
4/16/2024 - Tickeron - Stocks
Tourmaline Bio (NASDAQ:TRML) Shares Gap Up to $19.91
4/11/2024 - Ticker Report
Tourmaline Bio, Inc. (NASDAQ:TRML) Short Interest Up 123.1% in March
4/11/2024 - Ticker Report
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
4/2/2024 - Globe Newswire
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $55.60 Consensus Target Price from Analysts
3/31/2024 - Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$210.30M
Total Debt (Q)
$415.00K
Total Liabilities (Q)
$5.25M
Book Value Per Share (Q)
$10.08
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, March 19, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Week of Jul 15 and 19 (est)
Price History
Loading...
Beta
--
7-Day Total Return
-5.04%
30-Day Total Return
-62.03%
60-Day Total Return
-52.56%
90-Day Total Return
-20.80%
Year to Date Total Return
-40.23%
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Oct 23, 2023 - $9.18
52-week High
Mar 13, 2024 - $48.31
Valuation
Market Cap
$396.24M - Small Cap
Enterprise Value
$193.70M
Price/Sales (TTM)
--
Price/Book (Q)
1.53
Dividends and Shares
Shares Outstanding
16.00M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.tourmalinebio.com
Phone Number
646-481-9832
Address
27 West 24th Street
New York, NY 10010
Country
United States
Year Founded
2021
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6... more
NASDAQ 05/03/2024 4:00PM Eastern Quotes delayed
Weiss Ratings